CYP1A2 and ADORA2A Genotypes and Endurance Performance.

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Healthy

In brief

The aim of this randomized, double-blind, placebo-controlled experiment will be to assess the potential effect of the selected gene polymorphism (CYP1A2, ADORA2A) on performance after caffeine ingestion.

Key facts

Study ID

NCT06547307

Run by

Masaryk University

People needed

60

Starts

2024-08-01

Expected to finish

2025-03-01

Last updated by the study team

2024-08-09

Who can join

Age: 18 and older, up to 35. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• healthy person
• any training status
• within age limits
• without contraindications to perform the test on a bicycle trainer
• No contraindications to caffeine intake

You may not qualify if…

• Pregnancy
• Breast feeding
• Cardiovascular disease
• Hypertension
• Liver disease in the previous two months
• Taking drugs that can affect liver function
• Illness in the period of 14 days before the start of the research
• Use of caffeine during research

Where it is running

• Masaryk University — Brno, Czechia (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.